Back

TAVI for bicuspid aortic stenosis: Do or don't

27 August 2018 (11:45 - 12:07)
Organised by:
Congress Presentation Part of: Global perspectives on valvular heart disease Aortic Valve Stenosis ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Mao Chen

West China Hospital, Sichuan University, Chengdu (China)

3 More presentations in this session

Presentation thumbnail
The role of inflammation as treatment target in valve disease.
Professor D. Newby (Edinburgh, GB)
Slides Video
Presentation thumbnail
Geographical variation in epidemiology and management of degenerative valve disease.
Professor Y. Wu (Beijing, CN)
Presentation thumbnail
Challenges in valve disease for the next decade
Professor B. Prendergast (London, GB)
Slides Video

Access the full session

Session thumbnail
Global perspectives on valvular heart disease

The Event

Event poster

ESC Congress 2018

27 August 2018 11:45 CET
You may be interested in
thumbnail
Congress Presentation
Aortic stenosis: tricuspid vs. bicuspid aortic valve stenosis: does it really make a difference for patient management?
26 August 2022
thumbnail
Congress Presentation
Association between sex and transcatheter aortic valve replacement outcome for bicuspid and tricuspid aortic stenosis
1 September 2025
thumbnail
Congress Presentation
TAVI in younger patients: is it a reliable option?
9 March 2024
thumbnail
Congress Presentation
Echocardiographic results after complete transcatheter versus complete surgical treatment in patients with aortic valve stenosis and concomitant coronary artery disease
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources